Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer

Wei Zhao1,2, Qingyuan Zhu1, Peng Tan1,3

  • 1Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX, USA.

Insights

Targeting cellular plasticity in prostate cancer is crucial for overcoming treatment resistance. This study identifies key factors, including bone morphogenetic protein (BMP) signaling, that drive prostate cancer stemness and poor patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor mutations can induce cellular plasticity, leading to treatment resistance.
  • Novel strategies are needed to identify factors regulating cellular plasticity and combat chemoresistance.

Purpose of the Study:

  • To explore prostate epithelial cell reprogramming for identifying key factors in prostate cancer tumorigenesis and plasticity.
  • To investigate the roles of phosphatase and tensin homolog (Pten) and transforming growth factor-beta receptor type 2 (Tgfbr2) in prostate cancer progression.

Main Methods:

  • Utilized in vitro cell reprogramming and in vivo studies involving Pten and Tgfbr2 deletion in prostate epithelial cells.
  • Analyzed the impact of Tgfbr2 ablation on TGF-β and bone morphogenetic protein (BMP) signaling pathways.
  • Assessed the expression of tumor marker genes (ID1, Oct4, Nanog, Sox2) and their correlation with patient survival.

Main Results:

  • Deletion of Pten and Tgfbr2 enhanced prostate epithelial cell reprogramming efficiency and promoted rapid tumor development.
  • Tgfbr2 ablation suppressed TGF-β signaling while upregulating BMP signaling via Tmeff1.
  • Increased BMP signaling correlated with elevated expression of ID1, Oct4, Nanog, and Sox2, which were inversely linked to patient survival.

Conclusions:

  • Prostate epithelial cell reprogramming is a viable strategy to uncover factors driving cancer plasticity and tumorigenesis.
  • BMP signaling pathways play a critical role in conferring stemness to prostate tumor cells.
  • The ID1/STAT3/NANOG axis represents a potential therapeutic target for improving patient outcomes in prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K